Imaging research progress on complete pathological remission after neoadjuvant therapy for rectal cancer
10.3760/cma.j.cn431274-20230307-00303
- VernacularTitle:直肠癌新辅助治疗后病理学完全缓解的影像学研究进展
- Author:
Lirui WANG
1
;
Guozhu WU
Author Information
1. 内蒙古科技大学包头医学院研究生院，包头 014040
- Keywords:
Rectal neoplasms;
Neoadjuvant therapy;
Pathological complete response;
Imaging examination
- From:
Journal of Chinese Physician
2024;26(2):306-310
- CountryChina
- Language:Chinese
-
Abstract:
Rectal cancer is a common malignant tumor in China, with a high mortality rate ranking fifth. Neoadjuvant therapy for rectal cancer can improve patient prognosis and even achieve pathological complete remission (pCR) in some patients, thereby avoiding complications and functional damage caused by radical surgery. Therefore, how to accurately evaluate pCR before surgery is currently a research hotspot. In recent years, new imaging technologies such as endorectal ultrasound, magnetic resonance imaging (MRI), and positron emission computed tomography (PET-CT) have developed rapidly, and imaging evaluation of pCR after neoadjuvant therapy for rectal cancer has achieved good results. This article provides a review of this field, aiming to provide a basis for personalized treatment of rectal cancer patients.
